1型糖尿病的治疗进展及未来  

Progress and future in the treatment of type 1 diabetes mellitus

作　　者：周晶[1] 肖新华[1] Zhou Jing;Xiao Xinhua(Key Laboratory of Endocrinology,Ministry of Health,Department of Endocrinology,Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100730,China)

机构地区：[1]中国医学科学院北京协和医学院、北京协和医院内分泌科、国家卫生健康委内分泌重点实验室,北京100730

出　　处：《中国医学前沿杂志（电子版）》2024年第3期9-15,I0001,共8页Chinese Journal of the Frontiers of Medical Science(Electronic Version)

基　　金：国家自然科学基金面上项目(82170854,81870579,81870545);北京市自然科学基金面上项目(7202163);北京协和医院中央高水平医院临床科研专项重点培育项目(2022-PUMCH-C-019)。

摘　　要：近年来,1型糖尿病的治疗进入了新时代,各种新的治疗方式层出不穷,其中包括人工胰腺、新兴的药物疗法、干细胞疗法和人工智能等。本篇文章讨论了这些技术在糖尿病领域近5年的新进展,提出了未来发展的可能方向,为糖尿病的治疗提供新的思路与见解。In recent years,the treatment of type 1 diabetes mellitus has entered a new era with a variety of new therapeutic modalities,including artificial pancreas,emerging drug therapy,stem cell therapy,and artificial intelligence.This article discussed the new progress of technology in the field of diabetes in the past five years,put forward the possible direction of the future development and provided new ideas and insights for the treatment of diabetes.

关 键 词：1型糖尿病 人工胰腺 干细胞 人工智能 

分 类 号：R587.1[医药卫生—内分泌]